BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14722329)

  • 1. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
    Jutkiewicz EM; Eller EB; Folk JE; Rice KC; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 2004 Apr; 309(1):173-81. PubMed ID: 14722329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
    Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
    Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
    Psychopharmacology (Berl); 2002 Oct; 164(1):42-8. PubMed ID: 12373418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
    Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1337-48. PubMed ID: 16537798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
    Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
    Jutkiewicz EM; Walker NP; Folk JE; Rice KC; Portoghese PS; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1314-20. PubMed ID: 15574687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
    Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
    Stevenson GW; Folk JE; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptor.
    Xu H; Lu YF; Thomas JB; Carroll FI; Rice KC; Rothman RB
    Synapse; 2001 Jun; 40(4):269-74. PubMed ID: 11309842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of agonist and inverse agonist signaling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist.
    Piñeyro G; Azzi M; deLéan A; Schiller PW; Bouvier M
    Mol Pharmacol; 2005 Jan; 67(1):336-48. PubMed ID: 15496503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats.
    Bausch SB; Garland JP; Yamada J
    Brain Res; 2005 May; 1045(1-2):38-44. PubMed ID: 15910761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.
    Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
    Neuropsychopharmacology; 2002 Jun; 26(6):744-55. PubMed ID: 12007745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
    Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
    Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat.
    Cao CQ; Hong Y; Dray A; Perkins M
    Eur J Pharmacol; 2001 Apr; 418(1-2):79-87. PubMed ID: 11334868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
    Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.
    Schetz JA; Calderon SN; Bertha CM; Rice K; Porreca F
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1069-76. PubMed ID: 8968326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.